Atomic Invest’s Pfizer PFE Stock Holding History

Atomic Invest’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.45K	Sell	387 -532	-58%	-$13.9K	﹤0.01%	272
2026 Q1	$25.5K	Buy	919 +287	+45%	+$7.64K	0.01%	164
2025 Q4	$15.8K	Buy	+632	New	+$15.9K	0.01%	169

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Atomic Invest's PFE Position: Q2 2026 in Review

Atomic Invest reduced its Pfizer (PFE) stake by 58% in Q2 2026, selling an estimated $13.9K and leaving 387 shares worth $9.45K. The position accounts for ﹤0.01% of the portfolio, ranked #272.

Atomic Invest first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.5K in Q1 2026. 2,839 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Atomic Invest held 387 shares of Pfizer worth $9.45K as of Q2 2026.
Atomic Invest sold 532 Pfizer shares in Q2 2026, an estimated $13.9K.
Pfizer made up ﹤0.01% of Atomic Invest's portfolio in Q2 2026, its #272 holding.
Atomic Invest first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Atomic Invest's Pfizer position peaked at $25.5K in Q1 2026.
2,839 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Atomic Invest's 13F filing for Q2 2026, filed 25 Sep 2026.